When Are Oral Steroids Used for COPD? Side Effects Explained
At a Glance
Oral steroids such as prednisone are generally used for moderate to severe COPD flare-ups that need medical treatment, often for about five days. They can raise blood sugar and cause sleep or mood changes, while repeated courses increase longer-term risks.
WARNING: Seek Emergency Care Immediately
Do not wait to see if a steroid works if you are experiencing severe or rapidly worsening breathlessness, an inability to speak in full sentences, blue or gray lips, new confusion, extreme drowsiness, or severe chest pain. Steroids are not instant-relief medicines and they do not replace your rescue inhaler. Call emergency services right away if you experience these symptoms.
Oral corticosteroids (such as prednisone) are prescribed during acute COPD exacerbations—periods when your breathing symptoms, cough, or mucus production suddenly become much worse than your normal day-to-day baseline. These medicines work throughout your whole body (they are systemic) to quickly reduce airway inflammation. They are generally reserved for moderate to severe flare-ups under a doctor’s direction; they are not used to treat stable, everyday COPD symptoms [1].
When Are Oral Steroids Recommended?
Medical guidelines conditionally recommend a short course of oral corticosteroids for COPD exacerbations that require medical intervention [1]. If your flare-up is severe enough to require hospitalization, oral medicines are often preferred over intravenous (IV) steroids as long as you can safely take and absorb oral pills and do not have complications like severe vomiting or altered consciousness [1].
Research shows that a short course of about five days is just as effective at preventing relapse and hospital readmissions as longer courses (like 14 days), while safely limiting your overall exposure to the medicine’s side effects [2] [3]. A commonly recommended guideline regimen for adults is around 40 mg of prednisone (or a similar prednisone-equivalent drug) daily for this five-day period [4] [2].
Important: You must never choose your own dose or duration based on this general information. Your treating clinician will determine the exact prescription and duration based on your specific health profile.
Understanding Short-Term and Cumulative Side Effects
When a clinician determines that an exacerbation warrants systemic steroids, the short-term benefits of helping you breathe usually outweigh the risks [5]. However, even a short five-day course can cause temporary side effects:
- High Blood Sugar (Hyperglycemia): Steroids frequently cause spikes in blood glucose, which is a major concern for people with diabetes [6] [7] [8]. You may need to monitor your blood sugar more closely, but never change your diabetes medications on your own—always get a sick-day plan from your diabetes care team.
- Sleep and Mood Disturbances: Trouble sleeping (insomnia), anxiety, and sudden mood shifts are often reported by patients taking steroids [9]. However, the frightening physical stress of struggling to breathe during a severe flare-up can also cause or worsen these symptoms [10].
- Infection Risks: Because steroids temporarily suppress the immune system, they can increase your risk of infections like sepsis [11]. Severe opportunistic infections (infections that take advantage of a weakened immune system) are rare from a single short course, but they can occur in highly vulnerable individuals [12].
- Other Risks: Short courses of steroids have also been linked to an increased risk of blood clots (venous thromboembolism) and bone fractures [11].
Cumulative Risks: Taking these short courses multiple times carries a higher risk of long-term health problems. Repeated steroid use is linked to muscle weakness and wasting [13], bone thinning, and persistent blood sugar issues [8]. This is why doctors prescribe the shortest effective course possible.
The Danger of Self-Starting Leftover Medication
It can be tempting to reach for leftover steroid pills at the first sign of breathing trouble. However, unless you have a specific, written action plan from your doctor outlining exactly when to start a “rescue pack,” doing this is very dangerous.
Not every sudden breathing problem is a COPD exacerbation. Worsening breathlessness can actually be a sign of pneumonia, acute heart failure, or a blood clot in the lung (pulmonary embolism) [14] [15] [16].
Self-treating the wrong condition delays proper care [17]. A proper medical assessment might reveal you actually need different treatments instead:
- Antibiotics: These are only needed if a bacterial infection is suspected; they are not required for every COPD flare-up [18].
- Oxygen therapy: This is used and carefully monitored only when clinical tests show your oxygen levels are dangerously low [14].
- Hospital care: This may be necessary for severe cases, respiratory failure, or when you have other compounding health conditions [16] [14].
If you do not have a written action plan, always contact your care team for a proper medical assessment rather than guessing.
Common questions in this guide
When should a person with COPD take oral steroids for a flare-up?
How long do people usually take oral steroids for COPD?
What side effects can a short steroid course cause?
Are repeated steroid courses dangerous?
Can I use leftover prednisone at home when COPD symptoms start?
Which COPD symptoms mean I need emergency care?
Related questions
Show more
Get notified when new evidence is published on chronic obstructive pulmonary disease.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (18)
- 1
Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.
Wedzicha JA, Miravitlles M, Hurst JR, et al.
The European respiratory journal 2017; (49(3)) doi:10.1183/13993003.00791-2016.
PMID: 28298398 - 2
Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
Walters JA, Tan DJ, White CJ, Wood-Baker R
The Cochrane database of systematic reviews 2018; (3()):CD006897 doi:10.1002/14651858.CD006897.pub4.
PMID: 29553157 - 3
Extended Versus Short-Course Corticosteroid Taper Regimens in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Critically Ill Patients.
Poon T, Paris DG, Aitken SL, et al.
Journal of intensive care medicine 2020; (35(3)):257-263 doi:10.1177/0885066617741470.
PMID: 29161935 - 4
A multi-center randomized, controlled, open-label trial evaluating the effects of eosinophil-guided corticosteroid-sparing therapy in hospitalised patients with COPD exacerbations - The CORTICO steroid reduction in COPD (CORTICO-COP) study protocol.
Sivapalan P, Moberg M, Eklöf J, et al.
BMC pulmonary medicine 2017; (17(1)):114 doi:10.1186/s12890-017-0458-7.
PMID: 28810909 - 5
Influence of the Lung Microbiota Dysbiosis in Chronic Obstructive Pulmonary Disease Exacerbations: The Controversial Use of Corticosteroid and Antibiotic Treatments and the Role of Eosinophils as a Disease Marker.
Toraldo DM, Conte L
Journal of clinical medicine research 2019; (11(10)):667-675 doi:10.14740/jocmr3875.
PMID: 31636780 - 6
Efficacy and Safety of Different Doses of Systemic Corticosteroids in COPD Exacerbation.
Pu X, Liu L, Feng B, et al.
Respiratory care 2021; (66(2)):316-326 doi:10.4187/respcare.07925.
PMID: 33051255 - 7
Evaluation of the Impact of Corticosteroid Dose on the Incidence of Hyperglycemia in Hospitalized Patients with an Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Baker JM, Pace HA, Ladesich JB, Simon SD
Hospital pharmacy 2016; (51(4)):296-304 doi:10.1310/hpj5104-296.
PMID: 27303077 - 8
Corticosteroids for severe acute exacerbations of chronic obstructive pulmonary disease in intensive care: From the French OUTCOMEREA cohort.
Galerneau LM, Bailly S, Terzi N, et al.
PloS one 2023; (18(4)):e0284591 doi:10.1371/journal.pone.0284591.
PMID: 37075003 - 9
Investigating the risk factors for the coexistence of insomnia and its exacerbation in AECOPD.
Gao Q, Zhu H
Respiratory medicine 2025; (238()):107987 doi:10.1016/j.rmed.2025.107987.
PMID: 39921070 - 10
Investigation on the Relationship between Sleep Quality and Depression and Anxiety in Hospitalized Patients with Different Levels of AECOPD.
Liu D, Zou Y, Wang Y
Computational and mathematical methods in medicine 2022; (2022()):5901552 doi:10.1155/2022/5901552.
PMID: 35535231 - 11
Short term use of oral corticosteroids and related harms among adults in the United States: population based cohort study.
Waljee AK, Rogers MA, Lin P, et al.
BMJ (Clinical research ed.) 2017; (357()):j1415 doi:10.1136/bmj.j1415.
PMID: 28404617 - 12
Strongyloides stercoralis hyperinfection syndrome presenting as mechanical ileus after short-course oral steroids for chronic obstructive pulmonary disease (COPD) exacerbation.
Rothe K, Katchanov J, Schneider J, et al.
Parasitology international 2020; (76()):102087 doi:10.1016/j.parint.2020.102087.
PMID: 32087332 - 13
Deterioration of Limb Muscle Function during Acute Exacerbation of Chronic Obstructive Pulmonary Disease.
Abdulai RM, Jensen TJ, Patel NR, et al.
American journal of respiratory and critical care medicine 2018; (197(4)):433-449 doi:10.1164/rccm.201703-0615CI.
PMID: 29064260 - 14
Acute exacerbation of COPD.
Ko FW, Chan KP, Hui DS, et al.
Respirology (Carlton, Vic.) 2016; (21(7)):1152-65 doi:10.1111/resp.12780.
PMID: 27028990 - 15
Association Between the Inflammatory Biomarkers and Left Ventricular Systolic Dysfunction in Patients with Exacerbations of Chronic Obstructive Pulmonary Disease.
Andrijevic L, Milutinov S, Andrijevic I, et al.
Balkan medical journal 2017; (34(3)):226-231 doi:10.4274/balkanmedj.2016.1114.
PMID: 28443567 - 16
[Protocol for the management of patients with chronic obstructive pulmonary disease after exacerbation in the emergency department].
Ginel Mendoza L, Gonzálvez Rey J, Trigueros Carrero JA, Piñera Salmerón P
Semergen 2023; (49(6)):101998 doi:10.1016/j.semerg.2023.101998.
PMID: 37295262 - 17
Trends in Incidence, and Mortality of Acute Exacerbation of Chronic Obstructive Pulmonary Disease in the United States Emergency Department (2010-2018).
Nguyen PL, Uddin MM, Mir T, et al.
COPD 2021; (18(5)):567-575 doi:10.1080/15412555.2021.1979500.
PMID: 34530662 - 18
Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT.
Gkini E, Adams RL, Spittle D, et al.
Health technology assessment (Winchester, England) 2025; (29(28)):1-42 doi:10.3310/KPFD5558.
PMID: 40418146
This page explains when oral steroids may be used for a COPD exacerbation and the side effects they can cause; it is for information only and does not constitute medical advice. Do not self-start leftover medication—contact your care team for a personal plan, and seek emergency care for severe or rapidly worsening breathing symptoms.